• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M

Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M

March 18, 2014 By Arezu Sarvestani

Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M

Imaging technologies company Digirad Corp.(NSDQ:DRAD) acquired out-sourced cardiac monitoring services provider Telerhythmics in a deal worth up to $4.1 million.

The deal provides for about $3.5 million in cash, about $131,000 in debt and another possible $500,000 in earn-outs over the course of 3 years. The Telerhythmics team is planning to stay in Memphis, Tenn., rather than moving to join its new parent company in Suwanee, Ga., were Digirad moved its headquarters earlier this year.

"The addition of Telerhythmics fits squarely in our business model and our mission to provide medical services and technology on an as needed, where needed and when needed basis," Digirad president & CEO Matthew Molchan said in prepared remarks. "Its target market is virtually the same as our target market with DIS, and acquiring Telerhythmics allows us to drive additional services via our existing channels and expand and diversify our business operations, allowing us more opportunities to grow and broaden our geographic reach."

The announcement came a couple of weeks after Digirad announced its 4th-quarter earnings results, featuring a swing to the black for the full year. The company also announced recent efforts to cut costs my outsourcing some of its manufacturing.

For the 3 months ended December 31, Digirad posted profits of $787,000, or 4¢ per diluted share, on sales of $12.5 million. That compared with losses of $1.9 million, or 10¢ per share, on sales of $13 million during the same period the previous year.

For the full year, Digirad posted profits of $264,000, or 1¢ per share, on sales of $49.4 million. That compared with losses of $4.9 million, or 26¢ per share, on sales of $50.5 million in 2012. Adjusted for special items, 2013 per-share earnings amounted to 2¢, according to the report.

The company in January announced efforts to save some cash and streamline operations by shifting its headquarters to Georgia and moving its camera manufacturing, service and support operations to an outsourced provider in the San Diego area.

DRAD shares closed last night at $3.52, up 2.9% on the day. The stock has lost 4.9% since the start of the year.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Cardiac Rhythm Management, Digirad Corp., Remote Patient Monitoring, Telerhythmics

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy